Kamila Czene

Erasmus MC Cancer Institute — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

89h-index34.9kcitations744works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

BRCA gene mutations in cancer(234), Global Cancer Incidence and Screening(136), Breast Cancer Treatment Studies(135), Genetic Associations and Epidemiology(127), Cancer Risks and Factors(115)

Publications691 total

Additional file 1 of APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive disease
Figshare·2026Open Access
Additional file 1 of APOBEC3B protein expression associates with poor prognosis for breast cancer patients with ER-positive disease
Figshare·2026Open Access
Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts
UNC Libraries·2025Open Access
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients
UNC Libraries·2025Open Access
Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
2025Open Access
Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
2025Open Access
Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
2025Open Access
Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
2025Open Access
Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
2025Open Access
A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 womenLimited role for GxE interactions in BrCa risk
UNC Libraries·2025Open Access
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women
Cancers·2025Open Access
Screen-Detected Breast Cancer Outcomes by Mammography Participation in Immediate Past Screening
JAMA Network Open·2025Open Access
Evaluating distant recurrence‐free survival and location of metastasis in <scp>HER2</scp> + breast cancer by <scp>ER</scp> status
International Journal of Cancer·2025Open Access
Cancer risk after preeclampsia: a cohort study in two Nordic populations
BJC Reports·2025Open Access
Abstract GS2-10: A long-term image-derived AI risk model for primary prevention of breast cancer
Clinical Cancer Research·2025
Mammographic density, pathogenic breast cancer susceptibility gene variants and breast cancer risk
2025Open Access
Interactions between genetic and epidemiological factors influencing mammographic density
American Journal of Epidemiology·2025Open Access
Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp)
BMC Health Services Research·2025Open Access
Incorporating continuous mammographic density into the BOADICEA breast cancer risk prediction model
2025· 3 citedOpen Access
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial
JNCI Journal of the National Cancer Institute·2024· 4 citedOpen Access
page 1 of 35Next →

Frequent Co-authors

Per Hall(29), Stig E. Bojesen(26), Peter A. Fasching(26), Manjeet K. Bolla(25), Angela Cox(25), Joe Dennis(23), Carl Blomqvist(23), Javier Benı́tez(21), Barbara Burwinkel(21), Irene L. Andrulis(21), Graham G. Giles(21), Alison M. Dunning(20), Kyriaki Michailidou(19), Hiltrud Brauch(19), Thilo Dörk(19), Jenny Chang‐Claude(19), Matthias W. Beckmann(18), Hermann Brenner(18), Simon S. Cross(18), Peter Devilee(18)